Colonization of Pseudomonas aeruginosa at trachea, nares and oropharynx can cause ventilator-acquired pneumonia. To identify beneficial effects of antibiotics on expression of virulence factors related to colonization by such pathogens, we evaluated the effect of mupirocin on flagella formation in P. aeruginosa and on motility and flagella formation in Proteus mirabilis. In P. aeruginosa, subinhibitory concentrations of mupirocin inhibited flagella formation, which was associated with reduced flagellin expression. In P. mirabilis, subinhibitory concentrations of mupirocin dose-dependently suppressed bacterial motility and flagella formation, again with reduced flagellin expression. Our results indicate that subinhibitory concentrations of mupirocin can suppress expression of virulence factors in P. aeruginosa and P. mirabilis.
Introduction
Previous epidemiological analyses have shown that risk factors for ventilator-acquired pneumonia (VAP) include duration of mechanical ventilation, colonization of the upper respiratory tract and absence of antibiotic therapy. 1 Before the diagnosis of VAP, pathogens that have colonized trachea, nares and oropharynx are recovered from cultures of tracheal secretions. 1 The most common pathogens are Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus species. 1 Treatment with subinhibitory concentrations of some antibiotics suppresses expression of virulence factors in various Gram-negative bacteria. [2] [3] [4] [5] [6] [7] Macrolides and clindamycin inhibit biofilm formation in P. aeruginosa, 3, 5, 7 and macrolides suppress flagellin expression in both P. aeruginosa and Proteus mirabilis. 5 Recently, subinhibitory concentrations of azithromycin have been shown to interfere with synthesis of autoinducers such as 3-oxo-C 12 -homoserine lactone (HSL) and C 4 -HSL in the 'quorum-sensing' cell-to-cell signalling system, leading to reduction in virulence factors. 6 Some reports have suggested that treatment with subinhibitory concentrations of antibiotics such as macrolides may benefit patients with P. aeruginosa infections through inhibition of biofilm formation. 5, 6 To date, a limited number of antibiotics are known to have beneficial effects on expression of virulence factors at subinhibitory concentrations.
To identify beneficial effects of antibiotics on expression of virulence factors related to colonization by pathogens such as P. aeruginosa, we assessed the effect of mupirocin on flagella formation in P. aeruginosa. Additionally, we evaluated the effect of mupirocin on flagella formation and motility in P. mirabilis.
Materials and methods
Bacterial strains, media and culture conditions P. aeruginosa PAO-1 and a clinical isolate of P. mirabilis HU2001-309 were used. Bacteria were stored at -70°C in heart infusion broth (Nissui Pharmaceutical, Tokyo, Japan) containing 20% glycerol. Subsequently, bacteria were inoculated on heart infusion agar plates (Nissui Pharmaceutical) and incubated at 37°C overnight.
Susceptibility testing
The antibiotic used was mupirocin (GlaxoSmithKline, Tokyo, Japan), following an incidental observation of inhibition of swarming of P. mirabilis by this agent. MICs were determined by an agar dilution method as described by the National Committee for Clinical Laboratory Standards. 8 Susceptibility testing was carried out on Mueller-Hinton agar (Nippon Becton Dickinson, Tokyo, Japan) in accordance with the manufacturer's instructions.
Flagella preparation
Bacteria were cultured on heart infusion agar with either mupirocin or no antibiotic at 37°C for 12, 16 and 20 h. Bacteria were then gently scraped from the agar surface and suspended in PBS (pH 7.4). These samples were used for preparation of flagellin protein and for morphological observation by scanning electron microscopy (SEM). Flagellin protein was prepared by the method of Kawamura-Sato et al. 5, 9 The bacterial suspension was centrifuged (5000g) for 15 min at 4°C. The resulting pellet was resuspended in PBS and agitated with a tube mixer for 3 min to shear off the flagella. The suspension was centrifuged (16000g) for 15 min at 4°C, and the resulting supernatant was centrifuged (40000g) again for 3 h at 4°C. The supernatant was carefully removed and the pellet was suspended in PBS. The sample was analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The total protein concentrations in these samples were determined using a Micro BCA protein assay reagent kit (Pierce, Rockford, IL, USA). Concentrations of the flagellin protein were measured by the National Institutes of Health Image program, version 1.62, which is a public domain image of processing and analysis program for the Macintosh. 10 These experiments were carried out twice.
The criteria for quantifying flagella formation were defined as follows: high formation where the number and length were similar to formation with no antibiotic, moderate formation where the number was reduced but the length was preserved compared with formation with no antibiotic, and low formation where a small number of short flagella remained.
Scanning electron microscopy
Samples were fixed with Karnovsky's fixative (2% paraformaldehyde and 2.5% glutaraldehyde in PBS, pH 7.4), stained with 1% osmium tetroxide and 1% tannic acid and then dehydrated for 10 min in each of several increasing concentrations of ethanol (50, 70, 80, 90, 95 and 100% v/v), followed by two 10 min immersions in 100% 2-methyl-2-propanol at 45°C. Samples were freeze-dried (JFD-300; Jeol, Akishima, Japan) and osmium-coated with Plasma Multi Coater PMC-5000 (Meiwa Shoji, Osaka, Japan) for 16 s. Specimens were then examined with an S-800 electron microscope (Hitachi, Tokyo, Japan) at an accelerating voltage of 10 kV. 11 
Motility assay
Motility was assessed as described by Kawamura-Sato et al. 5 Bacteria grown in heart infusion broth at 37°C to an optical density of 0.1 at 660 nm were inoculated on to 0.3% heart infusion agar plates containing no antibiotic and 0.125, 0.25 and 0.5 × MIC of mupirocin for 18 h at 30°C. Diameters of growth zones were measured on the plates containing mupirocin or no antibiotic and were expressed as the mean ± S.D. for three experiments.
Statistical analysis
Statistical analysis was carried out using Microsoft Excel 97 Windows Edition. Results are expressed as mean ± S.D.
Results

Antibiotic susceptibility
The MIC of mupirocin was >8192 mg/L for P. aeruginosa PAO-1 and 128 mg/L for P. mirabilis HU2001-309.
Effect of mupirocin on flagella formation in P. aeruginosa
The effect of mupirocin at 64, 256 and 1024 mg/L on P. aeruginosa flagella formation was examined by SEM ( Figure  1c-f) . After 12 h of exposure to mupirocin, flagella formation was moderate at 1024 mg/L mupirocin, but flagella formation after exposure to both 64 and 256 mg/L mupirocin was high (data not shown). After 16 h of exposure, flagella formation was low at 1024 mg/L, moderate at 256 mg/L and high at 64 mg/L (Figure 1c-f) . To examine whether the reduced flagella formation was associated with loss of flagellin expression, the flagellin fraction of P. aeruginosa was prepared. Decrease in intensity of a single major band of the flagellin protein separated on an SDS-PAGE gel was related to suppression of flagella formation according to SEM (Figure 1a) . The quantitative estimates of the flagellin protein concentrations by the National Institutes of Health Image program were 108.86, 76.52, 60.98 and 40.96 for P. aeruginosa grown for 16 h on heart infusion plates containing 0, 64, 256 and 1024 mg/L mupirocin, respectively.
Effect of mupirocin on flagella formation and motility in P. mirabilis
The effect of 16, 32 and 64 mg/L mupirocin on flagella formation was examined in P. mirabilis (Figure 1g-j) . After 16 h of exposure to mupirocin, flagella formation was moderate at 16, 32 and 64 mg/L mupirocin (data not shown). After 20 h of exposure, flagella formation was low at 16, 32 and 64 mg/L mupirocin (Figure 1g-j) . As for P. aeruginosa, SDS-PAGE of the flagellin protein from P. mirabilis showed a decrease paralleling reduced flagella formation observed by SEM (Figure 1b) . The quantitative estimates of the flagellin protein concentrations by the National Institutes of Health Image program were 81.65, 66.15, 66.92 and 60.32 for P. mirabilis grown for 20 h on heart infusion plates containing 0, 16, 32 and 64 mg/L mupirocin, respectively. By motility assay in P. mirabilis, mupirocin at subinhibitory concentrations suppressed bacterial motility in a dose-dependent manner (Figure 2) .
Discussion
In the present study, we morphologically and biologically evaluated the effect of mupirocin on flagella formation in P. aeruginosa and on motility and flagella formation in P. mirabilis. Previous studies have shown that expression of virulence factors was suppressed by certain antibiotics such as macrolides and fluoroquinolones. 3, 5, 7, 12, 13 Some macrolides have been reported to inhibit biofilm formation by P. aeruginosa even below the MIC. 3, 5, 7 Our results indicated that mupirocin below the MIC can reduce expression of virulence factors in P. aeruginosa and P. mirabilis. The concentration examined should be clinically achievable, since the concentration of mupirocin applied topically as an ointment at intranasal sites is typically as high as 20000 mg/L. 14, 15 We showed that subinhibitory concentrations of mupirocin reduced flagella formation in P. aeruginosa and P. mirabilis. Previous reports have shown that subinhibitory concentrations of macrolides suppressed expression of flagellin dosedependently in P. aeruginosa and P. mirabilis. 5, 16 It has been suggested that flagella can have a role in the initiation of biofilm formation. 17 Subinhibitory concentrations of mupirocin dose-dependently suppressed bacterial motility in P. mirabilis while reducing flagella formation and flagellin expression. These results indicate that mupirocin inhibits motility by inhibition of the production of flagellin in P. mirabilis.
Mupirocin (pseudomonic acid A) derived from Pseudomonas fluorescens, inhibits bacterial growth by binding isoleucyl tRNA-synthetase encoded by the ileS gene and is mainly used as a topical agent to reduce spread of methicillinresistant Staphylococcus aureus (MRSA). The las cell-to-cell signalling system (i.e. the 'quorum-sensing' system) has been shown to participate in the differentiation of P. aeruginosa biofilms. 18, 19 The effect of mupirocin consisting of inhibiting expression of virulence factors may affect Pseudomonas biofilm formation via the quorum-sensing system but is unlikely to affect staphylococcal biofilm formation.
Low concentrations of mupirocin may contribute to mupirocin resistance in MRSA. 20 Thus, the use of subinhibitory concentrations of mupirocin could be detrimental, in view of the fact that plasmids can transfer mupirocin resistance among staphylococcus strains and that mupirocin resistance in staphylococci, usually mediated by a conjugative plasmidassociated ileS-2 gene, encoding an additional isoleucyl t-RNA-synthetase, is increasing. [21] [22] [23] [24] The possibility of the appearance of mupirocin plasmid-mediated resistance in the Pseudomonas and Proteus species remains unknown after treatment with subinhibitory concentrations of mupirocin but spread of mupirocin-resistant Staphylococcus strains has been shown in previous studies. [20] [21] [22] [23] [24] In conclusion, we have shown that subinhibitory concentrations of mupirocin can reduce flagellin expression and flagella formation in P. aeruginosa. In P. mirabilis, subinhibitory concentrations of mupirocin dose-dependently suppressed bacterial motility, flagellin expression and flagella formation. Thus, mupirocin showed important biological effects against P. aeruginosa and P. mirabilis at subinhibitory concentrations. Although further studies will be required, topical mupirocin may be useful in inhibiting initiation of biofilm formation in these pathogens.
